Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was approved in 202 as a treatment method for improving glycemic control in patients with Type 2 diabetes. Semaglutide shows great promise for patients who are having difficulty losing weight. Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control.

How it works! GLP-1 is a hormone produced in the small intestine that stimulates insulin secretion and inhibit glucagon secretion, thereby lowering blood sugar.

Aver Weight loss is 10-20lbs per month!!!